首页> 外国专利> 'method for recombinant expression of a human ccn1, use of a human ccn1, antibody against human ccn1, use of an antibody against human ccn1, method for the manufacture of a medicament for treating diseases and pharmaceutical composition'

'method for recombinant expression of a human ccn1, use of a human ccn1, antibody against human ccn1, use of an antibody against human ccn1, method for the manufacture of a medicament for treating diseases and pharmaceutical composition'

机译:“重组表达人ccn1的方法,人ccn1的用途,抗人ccn1的抗体,抗人ccn1的抗体的用途,制备治疗疾病的药物的方法和药物组合物”

摘要

Disclosed herein are methods for the recombinant expression of mammalian cell membrane-bound human CCN1 or a CCN1 domain thereof in mammalian cells, comprising transforming a mammalian host cell with a vector encoding CCN1 or a CCN1 domain thereof C-terminally fused to a mammalian cell transmembrane domain (CCN1 fusion protein), expressing said CCN1 or CCN1 domain fusion protein in said host cell, and recovering said membrane bound CCN1 or said CCN1 domain thereof. Disclosed herein is the use of such membrane bound CCN1 and domain for the generation of corresponding antibodies. Antibodies against human CCN1 are useful for the treatment of diseases.
机译:本文公开了在哺乳动物细胞中重组表达与哺乳动物细胞膜结合的人CCN1或其CCN1结构域的方法,包括用编码CCN1或其CCN1结构域的载体在C末端融合至哺乳动物细胞跨膜的载体转化哺乳动物宿主细胞。结构域(CCN1融合蛋白),在所述宿主细胞中表达所述CCN1或CCN1结构域融合蛋白,并回收所述膜结合的CCN1或其所述CCN1结构域。本文公开了这种膜结合的CCN1和结构域在产生相应抗体中的用途。针对人类CCN1的抗体可用于治疗疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号